SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-20-001714
Filing Date
2020-06-08
Accepted
2020-06-08 10:27:37
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13G sc13g07422cal_06082020.htm SC 13G 281928
2 JOINT FILING AGREEMENT ex991to13g07422cal_06082020.htm EX-99.1 10619
  Complete submission text file 0000921895-20-001714.txt   294092
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address KUNGSBRON 1, C8 STOCKHOLM V7 SE-111 22
Business Address KUNGSBRON 1, C8 STOCKHOLM V7 SE-111 22 46 8411 3005
Calliditas Therapeutics AB (Subject) CIK: 0001795579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91523 | Film No.: 20948339
SIC: 2834 Pharmaceutical Preparations